Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-Ichi Harada

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2005
Preoperative prediction of final pathological features is not improved by the free-to-total prostate-specific antigen ratio in Japanese men with clinically localized prostate cancerHideaki Miyake, Iori Sakai, Ken-Ichi Harada, et al.
The Journal of Antibiotics|August 3, 2005
Biotransformation of bile acids by pathogenic actinomycetes Nocardia otitidiscaviarum and Amycolatopsis sp. strainsAkira Mukai, Katsukiyo Yazawa, Yuzuru Mikami, et al.
Journal of Chromatography. A|August 28, 2010
Analytical aspects of cyanobacterial volatile organic compounds for investigation of their production behaviorDaiki Fujise, Kiyomi Tsuji, Naoko Fukushima, et al.
International Journal of Clinical Oncology|November 19, 2011
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Yuji Kusuda, Ken-ichi Harada, et al.
Urologic Oncology|July 26, 2011
Oncological outcome of docetaxel-based chemotherapy for Japanese men with metastatic castration-resistant prostate cancerHideaki Miyake, Iori Sakai, Tomoaki Terakawa, et al.
International Urology and Nephrology|June 26, 2012
Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years oldHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
International Journal of Clinical Oncology|May 28, 2004
Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese menIori Sakai, Ken-ichi Harada, Isao Hara, et al.
Molecular and Clinical Oncology|July 3, 2015
Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in JapanAkira Miyazaki, Hideaki Miyake, Ken-Ichi Harada, et al.
Journal of Chromatography. A|March 10, 2009
Application of log D for the prediction of hydrophobicity in the advanced Marfey's methodYuriko Nozawa, Akira Kawashima, Elisabete Hiromi Hashimoto, et al.
Current Urology|February 19, 2016
Oncological Outcomes in Japanese Men Undergoing Orchiectomy for Stage I Testicular Germ Cell TumorKen-Ichi Harada, Hideaki Miyake, Takayoshi Ogawa, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2005
Preoperative prediction of final pathological features is not improved by the free-to-total prostate-specific antigen ratio in Japanese men with clinically localized prostate cancerHideaki Miyake, Iori Sakai, Ken-Ichi Harada, et al.
The Journal of Antibiotics|August 3, 2005
Biotransformation of bile acids by pathogenic actinomycetes Nocardia otitidiscaviarum and Amycolatopsis sp. strainsAkira Mukai, Katsukiyo Yazawa, Yuzuru Mikami, et al.
Journal of Chromatography. A|August 28, 2010
Analytical aspects of cyanobacterial volatile organic compounds for investigation of their production behaviorDaiki Fujise, Kiyomi Tsuji, Naoko Fukushima, et al.
International Journal of Clinical Oncology|November 19, 2011
Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinomaHideaki Miyake, Yuji Kusuda, Ken-ichi Harada, et al.
Urologic Oncology|July 26, 2011
Oncological outcome of docetaxel-based chemotherapy for Japanese men with metastatic castration-resistant prostate cancerHideaki Miyake, Iori Sakai, Tomoaki Terakawa, et al.
International Urology and Nephrology|June 26, 2012
Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years oldHideaki Miyake, Iori Sakai, Ken-ichi Harada, et al.
International Journal of Clinical Oncology|May 28, 2004
Limited usefulness of the free-to-total prostate-specific antigen ratio for the diagnosis and staging of prostate cancer in Japanese menIori Sakai, Ken-ichi Harada, Isao Hara, et al.
Molecular and Clinical Oncology|July 3, 2015
Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in JapanAkira Miyazaki, Hideaki Miyake, Ken-Ichi Harada, et al.
Journal of Chromatography. A|March 10, 2009
Application of log D for the prediction of hydrophobicity in the advanced Marfey's methodYuriko Nozawa, Akira Kawashima, Elisabete Hiromi Hashimoto, et al.
Current Urology|February 19, 2016
Oncological Outcomes in Japanese Men Undergoing Orchiectomy for Stage I Testicular Germ Cell TumorKen-Ichi Harada, Hideaki Miyake, Takayoshi Ogawa, et al.
Pageof 15